IP Library Granted Patent US 11,007,181
Granted Patent B2
US 11,007,181 · App. 16/521,447 · Granted May 18, 2021

Cyclopamine analogs

Inventors: Brian Austad (Tewksbury, MA); Mark L. Behnke (Somerville, MA); Alfredo C. Castro (Woburn, MA); Michael J. Grogan (Winchester, MA); Somarajannair Janardanannair (Woburn, MA); Andre Lescarbeau (Somerville, MA); Stephane Peluso (Brookline, MA); Andre B. Charette (Longueuil, CA); Martin R. Tremblay (Melrose, MA)
Assignee: Infinity Pharmaceuticals, Inc.
A61K31/4355A61K9/0014A61K31/17A61K31/196A61K31/198A61K31/454A61K31/4745A61K31/519A61K31/56A61K31/573A61K31/58A61K31/664A61K31/69A61K31/704A61K31/7068A61K31/7076A61K38/21A61K45/06A61N5/10C07D307/94C07D471/04C07D471/10C07D491/04C07D491/048C07D491/10C07D491/107C07J69/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,007,181
App. No.
16/521,447
Granted
May 18, 2021
Kind
B2
Abstract

The invention provides derivatives of cyclopamine having the following formula:

Claims (3)

1. A hydrochloric acid salt of a compound having the structure:

wherein the hydrochloric acid salt is in the form of an iso-propanol solvate.

2. A pharmaceutical composition comprising the hydrochloric acid salt of claim 1 and a pharmaceutically acceptable excipient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: INFINITY PHARMACEUTICALS, INC.
To: ROYALTY SECURITY, LLC
Reel/Frame 051519/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2019
From: AUSTAD, BRIAN; BEHNKE, MARK L.; CASTRO, ALFREDO C.; GROGAN, MICHAEL J.; JANARDANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE; PELUSO, STEPHANE; CHARETTE, ANDRÉ B.; TREMBLAY, MARTIN
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 049853/0591 →
Continuity (8)
Continuation 15936919 · Mar 27, 2018
Continuation 15289887 · Oct 10, 2016
Continuation 14203297 · Mar 10, 2014
Continuation 12199722 · Aug 27, 2008
Continuation 11965688 · Dec 27, 2007
Provisional Application 60941596 · Jun 1, 2007
Provisional Application 60878018 · Dec 28, 2006
Related Publication 20200121658A1 · Apr 23, 2020
Cited By (1)
US 12,245,355